Return to search

Encision CEO Perner Dies, EDG Partners’ Dr. Pace to Replace Him

Encision said Tuesday that CEO Fred F. Perner died on August 31 from an apparent heart attack. He was 59. Dr. Pat Pace, who currently serves as the company’s chairman of the board and is an advisor to EDG Partners, a private equity firm that focuses on health care, will replace Perner. Based in Boulder, Colorado, Encision is a provider of surgical devices.

PRESS RELEASE

BOULDER, Colo., Sept. 3, 2013 /PRNewswire/ — Encision Inc. (ECIA:PK) announced today that Fred F. Perner, 59, its Chief Executive Officer died unexpectedly on August 31 from an apparent heart attack.
Mr. Perner joined Encision in September 2011 as its Chief Executive Officer. He had over 30 years of experience in healthcare, including many years of experience in electrosurgery and endoscopy technologies. He held B.S. and M.B.A. degrees from Indiana University and a law degree from the University of Denver.
To maintain continuity in the oversight of the Chief Executive Officer’s functions, the Board of Directors voted, effective today, to appoint Pat Pace, M.D. the company’s Chairman, as Executive Chairman of the Board of Directors. Dr. Pace is an Advisor to EDG Partners, a healthcare focused private equity firm. Dr. Pace’s background includes over 10 years of financial experience in the healthcare sector. From 2009 to 2011, he was a Managing Director at Citadel Securities, where he was part of the inaugural team that helped launch the firm’s investment banking and credit sales and trading efforts. In this capacity, he provided credit analysis for the healthcare sector. From 2006 to 2009, he was a Vice President at AIG Investments, where he focused on healthcare investments in the high yield bond market. From 2001 to 2006, Dr. Pace held various positions at UBS, including serving as Senior Analyst in equity research covering the medical device sector from 2003 to 2006. Dr. Pace also serves as Chairman of the board of directors for Nanospectra Biosciences, Inc., a privately held medical device company. Dr. Pace holds an M.D. from the University of Texas Medical School – Houston and a B.A. (Honors in Psychology) from Vanderbilt University.
“Fred’s leadership, energy, and vision that he dedicated to helping save patients’ lives will be severely missed,” said Encision’s Executive Chairman, Dr. Pace. “Fred had a vast knowledge of the medical device field, as well as friends and colleagues across the healthcare universe who were always eager to work with him. Our thoughts and prayers are with his wife and children.”
Encision Inc. designs, develops, manufactures and markets innovative surgical devices that allow surgeons to optimize technique and patient safety during a broad range of surgical procedures. Based in Boulder, Colorado, the Company pioneered the development of patented AEM® Laparoscopic Instruments to improve electrosurgery and reduce the chance for patient injury in minimally invasive surgery.